Bayer Pakistan rebuffs exit reports
KARACHI: German pharma major Bayer on Friday rebuffed reports of the company’s exit from Pakistan, stating it was not planning any such move.
In a statement, the company said, "Bayer is analysing which of its manufacturing activities may no longer be of strategic focus going forward. In doing so, the company intends to strengthen the competitiveness of its manufacturing capabilities and support the transformation of its pharmaceutical business to deliver long-term, sustainable business growth."
The company stated that it intended to transfer selected assets, i.e., its pharmaceutical and consumer health manufacturing plant based in Lahore, Pakistan, as well as selected brands from the pharmaceuticals and consumer health portfolios to an international diversified company with a strong presence in Pakistan.
-
AI Downtime Costs Surge As Automation Creates New Risks -
Nancy Guthrie Update: Ex-FBI Agent Spots Hidden Clues In Chilling Video -
Google To Release 32 Million Mosquitoes In Florida, California–Why Critics Are Concerned -
Queen Elizabeth's Legacy Falls Into Crisis: ‘They’ll Think She Protected Image Over Consequence’ -
220 Unicorn Startups Have Lost Their Billion-dollar Status. Here’s Why -
Halle Bailey Opens Up About 'motherhood' In Rare Personal Interview -
'Euphoria' Season 3 Pays Tribute To Angus Cloud -
Andrew Mountbatten-Windsor’s Next Victim Comes Forward -
'Euphoria' Star Alexa Demie Breaks Silence On Retirement Rumours -
Crypto Exchange Giant Binance Enters US Stock, ETF Trading -
What New Glenn’s Explosion Means For NASA’s Next Moon Missions -
Nancy Guthrie Kidnapping Case: Legal Expert Warns One ‘piece Of Evidence’ Could Mislead Investigators -
UFO Spotted Behind Active Volcano? Harvard Professor Exposes Real Truth -
Emma Corrin Discusses Decision To Return To Instagram: 'I Was Given No Choice' -
Anthropic To Grant EU Cybersecurity Agency ENISA Access To Mythos AI: Report -
Donald Trump Decides To Headline America 250 Concert After Major Artists Cancelled